Oz Vows To Defend Medicare Price Negotiations In Court Challenges, Open To Reference Pricing

Mehmet Oz, President Donald Trump's nominee to head CMS, told senators he would defend Medicare’s drug price negotiation program in court challenges, signaled an openness to international reference pricing and said pharmacy benefit managers’ practices need to be reformed. He also acknowledged -- but did not outright condemn -- the growing influence of private equity in health care during his Senate Finance Committee confirmation hearing Friday (March 14). The GOP-led committee will next schedule a vote on whether to advance...